Interacting Drugs |
Moclobemide vs Alpha2-Agonists (Ophthalmic) |
Security Level |
 |
Mechanism |
Alpha2-Agonists (Ophthalmic): MAO Inhibitors may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). |
Management |
Avoid combination |
Moclobemide vs Alpha2-Agonists (Ophthalmic)
Post Review about Moclobemide vs Alpha2-Agonists (Ophthalmic) Click here to cancel reply.
Other Interactions of Moclobemide
Other Interactions of Alpha2-Agonists (Ophthalmic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.